Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.
Non-Executive Director: |
Nicholas Mills, Robert (Rob) Graham Naylor |
Executive Chairman: |
Ian Johnson |
Senior Independent Director: |
Garry Watts |
Chief Finance Officer: |
Michael R D Roller |
Independent Non-Executive Director: |
Jo Le Couilliard, Sharon Curran |
Chief Operating Officer: |
Jonathan Emms |
Address: |
Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom |
Phone: |
+44 (0)1865 405560 |
Fax: |
+44 (0)7092 987560 |
Website: |
http://www.niox.com/ |
Email: |
|